The Valley Desk

NCT00277498 · Interventional trial

A 12-week, Randomized, Double-masked, Parallel Group Comparison of Evening Dosing With Xalacom in Subjects With Glaucoma

Overall registry status Completed

Phase 3

Conditions Ocular Hypertension, Open Angle Glaucoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov